80 related articles for article (PubMed ID: 22264762)
21. A Rapid and Specific HPLC Method to Determine Chemical and Radiochemical Purity of [
Migliari S; Sammartano A; Scarlattei M; Baldari G; Silva C; Ruffini L
Curr Radiopharm; 2021; 14(2):121-130. PubMed ID: 32990551
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of (68)Ga-labeled curcumin and curcuminoid complexes as potential radiotracers for imaging of cancer and Alzheimer's disease.
Asti M; Ferrari E; Croci S; Atti G; Rubagotti S; Iori M; Capponi PC; Zerbini A; Saladini M; Versari A
Inorg Chem; 2014 May; 53(10):4922-33. PubMed ID: 24766626
[TBL] [Abstract][Full Text] [Related]
23. Development and Evaluation of User-Friendly Single Vial DOTA-Peptide Kit Formulations, Specifically Designed for Radiolabelling with
Prince D; Rossouw D; Davids C; Rubow S
Mol Imaging Biol; 2017 Dec; 19(6):817-824. PubMed ID: 28341976
[TBL] [Abstract][Full Text] [Related]
24. A new (68)Ga anionic concentration and purification method for automated synthesis of [(68)Ga]-DOTA or NODAGA conjugated peptides in high radiochemical purity.
Ben Azzouna R; Alshoukr F; Leygnac S; Guez A; Gonzalez W; Rousseaux O; Guilloteau D; Le Guludec D
J Labelled Comp Radiopharm; 2015 Aug; 58(10):403-10. PubMed ID: 26242879
[TBL] [Abstract][Full Text] [Related]
25. C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4.
Suzuki K; Ui T; Nagano A; Hino A; Arano Y
Sci Rep; 2019 Oct; 9(1):15284. PubMed ID: 31653903
[TBL] [Abstract][Full Text] [Related]
26. In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines.
Di Cesare S; Marshall JC; Fernandes BF; Logan P; Antecka E; Filho VB; Burnier MN
Cancer Cell Int; 2007 Nov; 7():17. PubMed ID: 18001467
[TBL] [Abstract][Full Text] [Related]
27. The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.
Poschenrieder A; Schottelius M; Schwaiger M; Kessler H; Wester HJ
EJNMMI Res; 2016 Dec; 6(1):36. PubMed ID: 27112767
[TBL] [Abstract][Full Text] [Related]
28. Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents.
Lesniak WG; Sikorska E; Shallal H; Behnam Azad B; Lisok A; Pullambhatla M; Pomper MG; Nimmagadda S
Mol Pharm; 2015 Mar; 12(3):941-53. PubMed ID: 25590535
[TBL] [Abstract][Full Text] [Related]
29. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.
Wester HJ; Keller U; Schottelius M; Beer A; Philipp-Abbrederis K; Hoffmann F; Šimeček J; Gerngross C; Lassmann M; Herrmann K; Pellegata N; Rudelius M; Kessler H; Schwaiger M
Theranostics; 2015; 5(6):618-30. PubMed ID: 25825601
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, validation and quality controls of [68Ga]-DOTA-Pentixafor for PET imaging of chemokine receptor CXCR4 expression.
Sammartano A; Migliari S; Scarlattei M; Baldari G; Ruffini L
Acta Biomed; 2020 Jul; 91(4):e2020097. PubMed ID: 33525262
[TBL] [Abstract][Full Text] [Related]
31. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
Philipp-Abbrederis K; Herrmann K; Knop S; Schottelius M; Eiber M; Lückerath K; Pietschmann E; Habringer S; Gerngroß C; Franke K; Rudelius M; Schirbel A; Lapa C; Schwamborn K; Steidle S; Hartmann E; Rosenwald A; Kropf S; Beer AJ; Peschel C; Einsele H; Buck AK; Schwaiger M; Götze K; Wester HJ; Keller U
EMBO Mol Med; 2015 Apr; 7(4):477-87. PubMed ID: 25736399
[TBL] [Abstract][Full Text] [Related]
32. Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis.
Lucconi G; Cicoria G; Pancaldi D; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M
Appl Radiat Isot; 2013 Oct; 80():27-31. PubMed ID: 23816878
[TBL] [Abstract][Full Text] [Related]
33. A benzenesulfonamide derivative as a novel PET radioligand for CXCR4.
Oum YH; Shetty D; Yoon Y; Liang Z; Voll RJ; Goodman MM; Shim H
Bioorg Med Chem; 2020 Jan; 28(2):115240. PubMed ID: 31843463
[TBL] [Abstract][Full Text] [Related]
34. Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands.
Kwon D; Takata K; Zhang Z; Chong L; Fraser B; Zeisler J; Miyata-Takata T; Merkens H; Rousseau J; Aoki T; Kuo HT; Tan R; Zhang C; Lau J; Villa D; Uribe CF; Lin KS; Steidl C; Benard F
Clin Cancer Res; 2022 Apr; 28(8):1628-1639. PubMed ID: 35078860
[TBL] [Abstract][Full Text] [Related]
35. Scavenging strategy for specific activity improvement: application to a new CXCR4-specific cyclopentapeptide positron emission tomography tracer.
George GP; Pisaneschi F; Stevens E; Nguyen QD; Åberg O; Spivey AC; Aboagye EO
J Labelled Comp Radiopharm; 2013 Nov; 56(13):679-85. PubMed ID: 25196030
[TBL] [Abstract][Full Text] [Related]
36. CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma.
Herhaus P; Lipkova J; Lammer F; Yakushev I; Vag T; Slotta-Huspenina J; Habringer S; Lapa C; Pukrop T; Hellwig D; Wiestler B; Buck AK; Deckert M; Wester HJ; Bassermann F; Schwaiger M; Weber W; Menze B; Keller U
J Nucl Med; 2020 Dec; 61(12):1765-1771. PubMed ID: 32332145
[TBL] [Abstract][Full Text] [Related]
37. Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi
Suthiram J; Ebenhan T; Marjanovic-Painter B; Sathekge MM; Zeevaart JR
Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575402
[TBL] [Abstract][Full Text] [Related]
38. Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.
Liu N; Wan Q; Cheng Z; Chen Y
Curr Top Med Chem; 2019; 19(1):17-32. PubMed ID: 30706786
[TBL] [Abstract][Full Text] [Related]
39. Investigating CXCR4 expression of tumor cells and the vascular compartment: A multimodal approach.
Braga M; Leow CH; Gil JH; Teh JH; Carroll L; Long NJ; Tang MX; Aboagye EO
PLoS One; 2021; 16(11):e0260186. PubMed ID: 34793563
[TBL] [Abstract][Full Text] [Related]
40. Identification, characterization and suppression of side-products formed during the synthesis of high dose ⁶⁸Ga-DOTA-TATE.
Mu L; Hesselmann R; Oezdemir U; Bertschi L; Blanc A; Dragic M; Löffler D; Smuda C; Johayem A; Schibli R
Appl Radiat Isot; 2013 Jun; 76():63-9. PubMed ID: 22939572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
